Result description
iPROLEPSIS enters the quiet pauses when psoriatic arthritis interrupts a morning or drains energy without warning, turning daily reports and digital biomarkers into early flare predictions and coaching that arrives at the right moment.
AI PROGNOSIS moves with the changing rhythm of Parkinson’s, reading real‑life movement and sensor signals to foresee symptom shifts and guide steadier predictions and treatment choices.
REBECCA stays close to breast cancer survivors, shaping wearable data and lived stories into predictive insights that strengthen emotional recovery, stability and renewed confidence.
Addressing target audiences and expressing needs
- Grants and Subsidies
- Collaboration
- Fellowship to advance my/our research
Awareness of the output of the research results, effect on the regulatory bodies and translation to clinical practice.
- Public or private funding institutions
- Research and Technology Organisations
- Academia/ Universities
R&D, Technology and Innovation aspects
Development of digital biomarkers that provide predictive, and prognostic digital phenotyping information for better management of disease of psoriatic arthritis, Parkinson’s, and breast cancer.
